| Typicality: | 0.393 |
| Saliency: | 0.335 |
| for the condition | 5 | cause |
| in september | 5 | temporal |
| between 2013 | 4 | temporal |
| drug → be approved by → the european medicines agency | 19 |
| drug → be approved by → the european commission | 7 |
| drug → be approved by → european medicines agency | 5 |
| drug → be approved by → the eu medicines agency | 3 |
| drug → be approved by → the european medicine agency | 3 |
| negative | neutral | positive |
| 0.023 | 0.504 | 0.473 |
| Raw frequency | 37 |
| Normalized frequency | 0.335 |
| Modifier score | 0.500 |
| Perplexity | 12.610 |